Additionally, future research should determine the long-term effects of an increase in the central bioavailability of insulin and changes in serum GH on the generation of steatohepatitis and non-alcoholic fatty liver disease, since GH seems to play an important role in the progression of this disease, together with insulin resistance [57]. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.